article thumbnail

Understanding Rollover Equity

JD Supra: Mergers

For the right transaction, a rollover of equity can add value for the buyer and the seller. Rollover equity is ownership in the buyer or its affiliates that is issued to a seller as payment for all or a portion of the purchase price for a business.

Equities 165
article thumbnail

Bank of England Highlights Concerns With Private Equity Financing

JD Supra: Mergers

The Bank of England’s Financial Policy Committee (FPC) and the Prudential Regulation Authority (PRA) recently delivered a series of speeches1 raising their concerns about the evolution of private equity financing and the banking sector’s exposure to the private equity industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Federal Court Dismisses Antitrust Claims Against Private Equity Firm

JD Supra: Mergers

Private equity firms can breathe a sigh of relief after a federal judge dismissed claims that threatened to establish a precedent for holding private equity firms liable for certain actions by their portfolio companies. By: Troutman Pepper

article thumbnail

Corporate Transactions: Considerations for Addressing Equity Awards

JD Supra: Mergers

In corporate transactions of all kinds—mergers, acquisitions, and other business combinations—the purchaser company (Purchaser) must confront the question of how to treat the outstanding equity awards and the current equity incentive compensation plan of the target company in the transaction (Target). By: Morgan Lewis

Equities 159
article thumbnail

Private Equity Consolidation of Physician Practices Steady Despite Economic Conditions

JD Supra: Mergers

During the past 12 years, private equity (PE) firms have served as major investors in the U.S. health care market, participating in acquisitions and consolidations of physician practices across various specialties.

article thumbnail

Private Equity: Dealmaking on the Rebound?

Deal Lawyers

The fourth quarter of 2023 saw an uptick in global M&A activity that’s continued through the second quarter of 2024, but until recently, Private Equity didn’t appear to participate in the rebound. According to a new PitchBook report on PE deal activity, that started to change in the second quarter.

article thumbnail

Recent Ruling Shows Healthcare Private Equity Firms a Path Through the New Antitrust Era

JD Supra: Mergers

Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission's (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare "roll-up" strategy of its anesthesia practice management portfolio company. The case, Federal Trade Commission v.